Received Date : 20-Jan-2013 Revised
暂无分享,去创建一个
T. Spector | J. Malvehy | S. Puig | M. Iles | E. Guinó | D. Glass | V. Bataille | T. Bishop | N. Bonifaci | C. Badenas | M. Harland | Andrew A Brown | J. Newton-Bishop | I. Kolm | C. Carrera | M. Pujana | J. Puig-Butillé | Z. Ogbah | J. Randerson-Moor | M. Chan | F. Elliot
[1] H. Shaw,et al. A Phosphatidylinositol 3-Kinase–Pax3 Axis Regulates Brn-2 Expression in Melanoma , 2012, Molecular and Cellular Biology.
[2] Jeffrey E. Lee,et al. Genome-wide association study identifies three new melanoma susceptibility loci , 2011, Nature Genetics.
[3] Jeffrey E. Lee,et al. Genome-wide association study identifies nidogen 1 ( NID1 ) as a susceptibility locus to cutaneous nevi and melanoma risk , 2022 .
[4] Tsun-Po Yang,et al. Genevar: a database and Java application for the analysis and visualization of SNP-gene associations in eQTL studies , 2010, Bioinform..
[5] Nicole Soranzo,et al. IRF4 variants have age-specific effects on nevus count and predispose to melanoma. , 2010, American journal of human genetics.
[6] M. Ziman,et al. PAX3 Expression in Normal Skin Melanocytes and Melanocytic Lesions (Naevi and Melanomas) , 2010, PloS one.
[7] J. Barrett,et al. Vitamin D receptor gene polymorphisms, serum 25-hydroxyvitamin D levels, and melanoma: UK case-control comparisons and a meta-analysis of published VDR data. , 2009, European journal of cancer.
[8] T. Spector,et al. Genome-wide association study identifies variants at 9p21 and 22q13 associated with development of cutaneous nevi , 2009, Nature Genetics.
[9] M. Ziman,et al. PAX3 across the spectrum: from melanoblast to melanoma , 2009, Critical reviews in biochemistry and molecular biology.
[10] J. Malvehy,et al. Prevalence Study of Nevi in Children from Barcelona , 2008, Dermatology.
[11] C. Shea,et al. PAX3 expression in primary melanomas and nevi , 2008, Modern Pathology.
[12] T. Spector,et al. Genome-wide search for nevus density shows linkage to two melanoma loci on chromosome 9 and identifies a new QTL on 5q31 in an adult twin cohort. , 2006, Human molecular genetics.
[13] S. O’Day,et al. Multimarker quantitative real-time PCR detection of circulating melanoma cells in peripheral blood: relation to disease stage in melanoma patients. , 2005, Clinical chemistry.
[14] J. Epstein,et al. Pax3 functions at a nodal point in melanocyte stem cell differentiation , 2005, Nature.
[15] J. Barrett,et al. The effect of sun exposure in determining nevus density in UK adolescent twins. , 2005, The Journal of investigative dermatology.
[16] P. Boyle,et al. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. , 2005, European journal of cancer.
[17] J. Barrett,et al. Heritability and gene-environment interactions for melanocytic nevus density examined in a U.K. adolescent twin study. , 2001, The Journal of investigative dermatology.
[18] R. Dummer,et al. PAX3 is expressed in human melanomas and contributes to tumor cell survival. , 2001, Cancer research.
[19] P Sasieni,et al. Genetics of risk factors for melanoma: an adult twin study of nevi and freckles. , 2000, Journal of the National Cancer Institute.
[20] J. A. Bishop,et al. Genotype/phenotype and penetrance studies in melanoma families with germline CDKN2A mutations. , 2000, The Journal of investigative dermatology.
[21] J F Aitken,et al. A major quantitative-trait locus for mole density is linked to the familial melanoma gene CDKN2A: a maximum-likelihood combined linkage and association analysis in twins and their sibs. , 1999, American journal of human genetics.
[22] X. Estivill,et al. Inherited susceptibility to several cancers but absence of linkage between dysplastic nevus syndrome and CDKN2A in a melanoma family with a mutation in the CDKN2A (P16INK4A) gene , 1997, Human Genetics.
[23] B. Assouline,et al. Familial aggregation of malignant melanoma/dysplastic naevi and tumours of the nervous system: an original syndrome of tumour proneness. , 1997, Annales de genetique.